New drug duo aims to wipe out rare blood disease
Disease control
Recruiting now
This study tests whether two drugs, teclistamab and daratumumab, can safely and effectively treat AL amyloidosis, a rare disease where abnormal proteins damage organs. About 25 adults with newly diagnosed disease will receive the combination for 6 months. The main goal is to see …
Phase: PHASE2 • Sponsor: Suzanne Lentzsch, MD • Aim: Disease control
Last updated May 22, 2026 13:53 UTC